维普中文期刊产品整合服务

Long-range gene regulation network of the MGMT enhancer modulates glioma cell sensitivity to temozolomide

查看全文 作  者:Bohan [1]Chen;Anshun [1]He;Jinfang [1]Bi;Shupeng [2]Sun;Yiping [1]Ma;Wenbin [1]Wang;Dianhao [1]Guo;Jun [1]Chen;Yuyang [1]Qian;Tengfei [1]Shi;Guohui [3]Nie;Zhongfang [1]Zhao;Jiandang [1]Shi;Hongzhen [1]Yang;Lei [1]Zhang;Wange [1]Lu 高影响力作者 机构地区:[1]State Key Laboratory of Medicinal Chemical Biology and College of Life Sciences,Nankai University,94 Weijin Road,Tianjin 300071,China;[2]Department of Neurosurgery,Tianjin Huanhu Hospital,School of Medicine,Nankai University,6 Jizhao Road,Tianjin 300350,China;[3]Department of Otolaryngology,The First Affiliated Hospital of Shenzhen University,Shenzhen Second People's Hospital,Shenzhen 518035,China高影响力机构 出  处:《Journal of Genetics and Genomics》索引2021年第48卷第10期,共4页高影响力期刊 基  金:supported by the National Natural Science Foundation of China(31701129,31530027,and 81772687);the Natural Science Foundation of Tianjin City of China(20JCQNJC01880,18JCQNJC10100,and 18JCQNJC09800);National Key R&D Program of China(2017YFA0102600);the Fundamental Research Funds for the Central Universities,Nankai University(63201087)。 摘  要:Approximately 80%of primary tumors in the central nervous system are malignant glioma,and>50%of those are diagnosed as glioblastoma(GBM),the most aggressive glioma.Despite treatment advances,GBM prognosis is unsatisfying,and the median survival time of patients is only 14-17 months. 关 键 词:GLIOMA PROGNOSIS MGMT
相关文献

参考文献(20)

引证文献(1)

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费